data_2fvn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fvn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 151.71 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.18 86.74 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.608 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 2.2 mm? -103.68 102.89 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -128.65 115.05 17.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.512 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD11 ' OG1' ' A' ' 137' ' ' THR . 8.2 mt -82.21 162.32 22.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -152.97 111.25 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -96.45 91.96 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -26.04 50.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.34 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.15 133.4 10.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.647 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . -57.53 -94.26 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.65 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -178.54 171.33 1.56 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 111.316 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' CA ' HG13 ' A' ' 141' ' ' VAL . . . 66.16 18.69 67.35 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.215 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -97.43 30.52 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 58.91 95.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -76.56 120.06 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.209 -178.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -72.63 143.68 48.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.918 ' O ' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -28.46 -32.21 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -177.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 98' ' ' ALA . . . -119.93 -56.46 0.25 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.336 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 19' ' ' GLY . . . -6.47 110.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 122.888 1.328 . . . . 0.0 113.837 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.69 ' HA ' ' H ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -63.22 -156.77 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 112.024 -2.353 . . . . 0.0 112.071 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.98 -65.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 137' ' ' THR . . . -104.58 113.85 27.69 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 97.4 m -116.74 93.66 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.69 0.281 . . . . 0.0 110.654 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.07 -159.46 22.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.849 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.23 137.68 10.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 117' ' ' CYS . 8.8 tt -109.27 153.65 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.419 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.67 130.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.704 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -125.93 -162.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.888 -135.61 54.087 71.332 103.417 2.022 103.025 90.255 95.576 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 29' ' ' CYS . 1.4 ptt85 166.08 38.82 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -144.17 170.34 16.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.928 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -70.01 110.9 5.33 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.536 ' CE1' ' CG ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.29 167.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.278 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.94 36.09 4.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.511 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.912 ' HA2' ' O ' ' A' ' 85' ' ' ARG . . . -169.2 150.76 16.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 118.629 -1.748 . . . . 0.0 116.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.976 ' O ' ' HA ' ' A' ' 84' ' ' SER . 3.6 m-85 -103.61 127.71 51.0 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.651 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.3 OUTLIER -110.01 109.98 20.74 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 8.3 p -126.24 158.5 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.786 ' NE1' ' HA3' ' A' ' 114' ' ' GLY . 11.4 p90 -139.08 175.63 9.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.814 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.507 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -118.44 -23.61 7.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.096 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.7 4.05 4.31 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 23.3 mm-40 -98.15 65.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.37 -0.206 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.94 -152.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.22 154.43 23.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 9.0 p -107.82 131.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.864 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.1 -66.11 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.568 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.47 64.47 0.07 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.089 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -113.87 -96.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' O ' ' CE2' ' A' ' 52' ' ' TYR . . . 146.12 -18.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 51' ' ' ARG . 18.5 pt-20 -92.88 -155.59 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.672 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' C ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -30.62 115.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.294 0.497 . . . . 0.0 111.196 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -151.49 131.08 13.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' CG2' ' HD3' ' A' ' 64' ' ' ARG . 1.5 t -72.71 124.62 29.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.0 0.905 . . . . 0.0 111.877 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 14.8 m -99.64 159.79 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.432 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -106.78 175.43 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.156 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' CD2' ' A' ' 61' ' ' HIS . 3.3 p -87.45 -159.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.709 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.44 -27.77 11.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.97 20.55 6.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.429 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 38.24 70.5 0.28 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.628 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -163.92 8.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -169.32 157.97 7.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 111.142 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -121.07 142.94 49.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.237 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.65 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 3.2 tt -118.24 95.89 5.08 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.32 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . 2.3 mmt85 -53.57 159.54 1.49 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.674 -0.641 . . . . 0.0 111.408 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -154.45 158.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.493 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 51.7 mtp85 -138.48 137.61 37.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -175.5 -70.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 72' ' ' TRP . . . -65.6 15.46 0.22 Allowed Glycine 0 CA--C 1.503 -0.707 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.606 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' THR . . . -143.93 13.68 2.16 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.768 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 69' ' ' GLY . 27.7 t70 -49.91 -61.18 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 103.549 -2.759 . . . . 0.0 103.549 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.13 5.46 0.66 Allowed Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.595 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 17.3 m95 -51.38 -170.73 0.0 OUTLIER 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.044 0.937 . . . . 0.0 110.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -137.57 130.37 16.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.776 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 22.4 Cg_endo -59.87 119.02 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.955 1.77 . . . . 0.0 111.628 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 37' ' ' HIS . 63.7 t -123.28 151.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -67.49 91.37 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.99 121.37 5.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.532 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -45.49 145.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 111.073 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . 76.85 41.48 23.18 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.023 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.31 -70.75 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.732 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.16 162.55 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 112.071 -178.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.63 103.25 1.38 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.538 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 49' ' ' ALA . 27.1 m -136.28 154.45 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.976 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -124.89 140.98 52.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.991 1.377 . . . . 0.0 114.3 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.912 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -105.77 177.18 1.43 Allowed Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.616 ' C ' ' O ' ' A' ' 85' ' ' ARG . 99.2 Cg_exo -38.89 134.6 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 105.964 -2.36 . . . . 0.0 105.964 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -117.74 -47.46 0.45 Allowed Glycine 0 CA--C 1.5 -0.877 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.093 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -33.31 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.646 0.736 . . . . 0.0 110.346 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.721 ' N ' ' O ' ' A' ' 87' ' ' GLY . 12.8 tp10 -54.2 142.78 24.77 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.624 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -42.91 77.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.94 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -172.89 138.75 0.81 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.481 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' A' ' 36' ' ' PHE . 33.1 m -130.84 122.31 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.942 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -85.22 119.84 26.04 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CZ ' HG22 ' A' ' 38' ' ' VAL . 14.8 p90 -98.89 131.15 45.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.058 -0.401 . . . . 0.0 110.34 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 4.1 p30 -91.42 147.39 23.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.7 m -107.54 106.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.671 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -86.31 109.63 19.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.853 0.835 . . . . 0.0 110.968 -176.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.69 ' H ' ' HA ' ' A' ' 21' ' ' LYS . . . -70.5 108.18 4.19 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.96 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.918 ' HA ' ' O ' ' A' ' 18' ' ' ASP . 59.2 t0 -81.3 68.06 7.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.602 0.715 . . . . 0.0 110.78 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 101' ' ' ASN . . . -77.52 -93.75 0.24 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.616 ' O ' ' CB ' ' A' ' 102' ' ' GLN . 0.1 OUTLIER 84.69 72.2 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.814 0.807 . . . . 0.0 110.875 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 3.4 tt0 136.56 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.249 0.62 . . . . 0.0 110.763 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.46 135.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 104' ' ' ILE . 17.2 pt -85.7 105.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.419 0.628 . . . . 0.0 112.464 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 104' ' ' ILE . . . -25.19 133.54 0.1 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.31 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 61.8 Cg_exo -50.9 161.57 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.466 2.111 . . . . 0.0 112.466 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 61' ' ' HIS . . . 124.09 -162.71 18.08 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' HB2' ' A' ' 138' ' ' LYS . 3.5 tm-20 -125.54 138.99 53.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.948 0.374 . . . . 0.0 111.369 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 16.1 m-85 -117.64 146.83 43.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -124.16 126.99 47.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.042 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 137' ' ' THR . 16.3 m-85 -127.27 119.51 26.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.259 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 14.0 m -107.83 117.75 34.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.69 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -79.03 175.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.118 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.786 ' HA3' ' NE1' ' A' ' 39' ' ' TRP . . . 170.5 68.51 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.401 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 37' ' ' HIS . . . -86.22 93.18 1.84 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.61 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' A' ' 117' ' ' CYS . . . -61.29 -47.58 85.33 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 117.499 0.649 . . . . 0.0 111.998 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.617 ' N ' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER 90.58 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.904 0.752 . . . . 0.0 110.932 -179.513 95.576 90.255 71.332 103.025 2.022 103.417 54.087 -135.61 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.58 142.33 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.754 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.3 99.17 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.01 139.51 88.11 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.1 175.02 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.99 87.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.97 165.97 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -70.62 -64.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -131.11 132.01 44.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.64 152.11 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.24 -150.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.241 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 128' ' ' PHE . 2.4 p90 -156.0 117.31 3.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 111.226 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.1 p -145.58 75.93 13.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -99.64 71.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.689 2.926 . . . . 0.0 111.961 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -44.72 0.22 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.855 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' HA3' ' HH2' ' A' ' 39' ' ' TRP . . . 61.8 152.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.615 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -52.71 172.85 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -145.39 145.9 31.34 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.907 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' A' ' 112' ' ' SER . . . -157.4 159.38 29.72 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.604 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.761 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -110.85 171.49 7.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.967 -0.617 . . . . 0.0 110.051 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.807 ' OG1' HD11 ' A' ' 6' ' ' LEU . 2.5 m 177.14 95.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -110.86 137.14 48.88 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.538 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -97.21 112.99 24.54 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.777 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 108' ' ' GLU . 2.0 m -87.0 105.35 17.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.7 OUTLIER -103.41 138.88 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.107 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 28' ' ' ILE . . . -148.31 151.71 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' C ' HD22 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -157.18 86.74 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 2.2 mm? -103.68 102.89 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -128.65 115.05 17.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.512 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.005 HD11 ' HB ' ' A' ' 113' ' ' VAL . 8.2 mt -82.21 162.32 22.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -152.97 111.25 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -96.45 91.96 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -26.04 50.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.34 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.15 133.4 10.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.647 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.981 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -57.53 -94.26 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.65 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.733 ' OG ' HG22 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -178.54 171.33 1.56 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 111.316 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.751 ' N ' HG13 ' A' ' 141' ' ' VAL . . . 66.16 18.69 67.35 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.215 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -97.43 30.52 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 58.91 95.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -76.56 120.06 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.209 -178.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -72.63 143.68 48.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.959 ' O ' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -28.46 -32.21 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -177.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 98' ' ' ALA . . . -119.93 -56.46 0.25 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.336 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -6.47 110.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 122.888 1.328 . . . . 0.0 113.837 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.724 ' HA ' ' H ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -63.22 -156.77 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 112.024 -2.353 . . . . 0.0 112.071 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -166.98 -65.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.219 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.808 ' O ' HG13 ' A' ' 96' ' ' VAL . . . -104.58 113.85 27.69 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 97.4 m -116.74 93.66 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.69 0.281 . . . . 0.0 110.654 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.07 -159.46 22.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.879 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.23 137.68 10.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.734 HD11 ' N ' ' A' ' 117' ' ' CYS . 8.8 tt -109.27 153.65 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.419 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -139.67 130.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.704 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -125.93 -162.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.888 -135.61 54.087 71.332 103.417 2.022 103.025 90.255 95.576 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 29' ' ' CYS . 1.4 ptt85 166.08 38.82 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -144.17 170.34 16.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.928 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -70.01 110.9 5.33 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.536 ' CE1' ' CG ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.29 167.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.278 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.94 36.09 4.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.511 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.929 ' HA2' ' O ' ' A' ' 85' ' ' ARG . . . -169.2 150.76 16.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 118.629 -1.748 . . . . 0.0 116.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 84' ' ' SER . 3.6 m-85 -103.61 127.71 51.0 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.664 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.3 OUTLIER -110.01 109.98 20.74 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.671 HG12 ' CZ3' ' A' ' 72' ' ' TRP . 8.3 p -126.24 158.5 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.817 ' NE1' ' HA3' ' A' ' 114' ' ' GLY . 11.4 p90 -139.08 175.63 9.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.814 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.536 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -118.44 -23.61 7.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.096 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 112' ' ' SER . 0.1 OUTLIER 74.7 4.05 4.31 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.791 ' HB2' HG12 ' A' ' 54' ' ' VAL . 23.3 mm-40 -98.15 65.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.37 -0.206 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.94 -152.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 0.8 OUTLIER -160.22 154.43 23.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 9.0 p -107.82 131.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.864 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.1 -66.11 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.568 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.47 64.47 0.07 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.089 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -113.87 -96.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.846 ' CB ' HG13 ' A' ' 83' ' ' VAL . . . 146.12 -18.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 51' ' ' ARG . 18.5 pt-20 -92.88 -155.59 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.672 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' C ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -30.62 115.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.294 0.497 . . . . 0.0 111.196 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -151.49 131.08 13.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 64' ' ' ARG . 1.5 t -72.71 124.62 29.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.0 0.905 . . . . 0.0 111.877 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.791 HG12 ' HB2' ' A' ' 42' ' ' GLU . 14.8 m -99.64 159.79 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.432 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -106.78 175.43 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.156 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' CD2' ' A' ' 61' ' ' HIS . 3.3 p -87.45 -159.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.709 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.44 -27.77 11.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.97 20.55 6.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.429 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 38.24 70.5 0.28 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.628 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -163.92 8.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -169.32 157.97 7.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 111.142 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -121.07 142.94 49.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.237 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.006 HD22 ' CZ ' ' A' ' 111' ' ' PHE . 3.2 tt -118.24 95.89 5.08 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.32 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.725 ' HD3' HG22 ' A' ' 53' ' ' VAL . 2.3 mmt85 -53.57 159.54 1.49 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.674 -0.641 . . . . 0.0 111.408 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG13 HD23 ' A' ' 63' ' ' LEU . 17.5 m -154.45 158.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.493 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 51.7 mtp85 -138.48 137.61 37.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -175.5 -70.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.901 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -65.6 15.46 0.22 Allowed Glycine 0 CA--C 1.503 -0.707 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.606 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 67' ' ' THR . . . -143.93 13.68 2.16 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.768 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 69' ' ' GLY . 27.7 t70 -49.91 -61.18 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 103.549 -2.759 . . . . 0.0 103.549 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.13 5.46 0.66 Allowed Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.671 ' CZ3' HG12 ' A' ' 38' ' ' VAL . 17.3 m95 -51.38 -170.73 0.0 OUTLIER 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.044 0.937 . . . . 0.0 110.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.57 130.37 16.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.776 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 83' ' ' VAL . 22.4 Cg_endo -59.87 119.02 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.955 1.77 . . . . 0.0 111.628 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG12 ' CE1' ' A' ' 37' ' ' HIS . 63.7 t -123.28 151.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -67.49 91.37 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.99 121.37 5.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.532 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -45.49 145.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 111.073 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 81' ' ' LYS . . . 76.85 41.48 23.18 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.023 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.31 -70.75 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.732 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.16 162.55 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 112.071 -178.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.61 ' N ' ' HB1' ' A' ' 49' ' ' ALA . . . 125.63 103.25 1.38 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.538 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 68' ' ' GLY . 27.1 m -136.28 154.45 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.935 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -124.89 140.98 52.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.991 1.377 . . . . 0.0 114.3 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.929 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -105.77 177.18 1.43 Allowed Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.616 ' C ' ' O ' ' A' ' 85' ' ' ARG . 99.2 Cg_exo -38.89 134.6 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 105.964 -2.36 . . . . 0.0 105.964 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -117.74 -47.46 0.45 Allowed Glycine 0 CA--C 1.5 -0.877 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.093 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -33.31 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.646 0.736 . . . . 0.0 110.346 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.721 ' N ' ' O ' ' A' ' 87' ' ' GLY . 12.8 tp10 -54.2 142.78 24.77 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.624 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -42.91 77.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.94 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -172.89 138.75 0.81 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.481 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.728 HG22 ' CD2' ' A' ' 36' ' ' PHE . 33.1 m -130.84 122.31 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.942 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.879 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -85.22 119.84 26.04 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 14.8 p90 -98.89 131.15 45.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.058 -0.401 . . . . 0.0 110.34 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 4.1 p30 -91.42 147.39 23.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 23' ' ' ALA . 1.7 m -107.54 106.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -86.31 109.63 19.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.853 0.835 . . . . 0.0 110.968 -176.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -70.5 108.18 4.19 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.96 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.959 ' HA ' ' O ' ' A' ' 18' ' ' ASP . 59.2 t0 -81.3 68.06 7.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.602 0.715 . . . . 0.0 110.78 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -77.52 -93.75 0.24 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.643 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER 84.69 72.2 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.814 0.807 . . . . 0.0 110.875 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 3.4 tt0 136.56 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.249 0.62 . . . . 0.0 110.763 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.46 135.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 104' ' ' ILE . 17.2 pt -85.7 105.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.419 0.628 . . . . 0.0 112.464 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 104' ' ' ILE . . . -25.19 133.54 0.1 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.31 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 61.8 Cg_exo -50.9 161.57 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.466 2.111 . . . . 0.0 112.466 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 141' ' ' VAL . . . 124.09 -162.71 18.08 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.5 tm-20 -125.54 138.99 53.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.948 0.374 . . . . 0.0 111.369 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HE1' HG21 ' A' ' 141' ' ' VAL . 16.1 m-85 -117.64 146.83 43.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -124.16 126.99 47.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.042 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.006 ' CZ ' HD22 ' A' ' 63' ' ' LEU . 16.3 m-85 -127.27 119.51 26.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.259 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 14.0 m -107.83 117.75 34.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.005 ' HB ' HD11 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -79.03 175.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.118 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.817 ' HA3' ' NE1' ' A' ' 39' ' ' TRP . . . 170.5 68.51 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.401 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' HA2' ' O ' ' A' ' 37' ' ' HIS . . . -86.22 93.18 1.84 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.61 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . -61.29 -47.58 85.33 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 117.499 0.649 . . . . 0.0 111.998 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.734 ' N ' HD11 ' A' ' 27' ' ' ILE . 0.5 OUTLIER 90.58 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.904 0.752 . . . . 0.0 110.932 -179.513 95.576 90.255 71.332 103.025 2.022 103.417 54.087 -135.61 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 117' ' ' CYS . 16.1 t -100.58 142.33 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.754 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.3 99.17 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.01 139.51 88.11 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.1 175.02 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.99 87.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.97 165.97 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -70.62 -64.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -131.11 132.01 44.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.64 152.11 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.24 -150.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.241 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 128' ' ' PHE . 2.4 p90 -156.0 117.31 3.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 111.226 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.1 p -145.58 75.93 13.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -99.64 71.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.689 2.926 . . . . 0.0 111.961 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -44.72 0.22 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.855 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' ALA . . . 61.8 152.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.615 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.619 ' CG2' ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -52.71 172.85 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 133' ' ' THR . 75.8 p -145.39 145.9 31.34 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.907 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.807 ' HA3' HG12 ' A' ' 113' ' ' VAL . . . -157.4 159.38 29.72 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.604 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -110.85 171.49 7.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.967 -0.617 . . . . 0.0 110.051 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.591 HG21 ' CB ' ' A' ' 23' ' ' ALA . 2.5 m 177.14 95.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -110.86 137.14 48.88 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.538 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -97.21 112.99 24.54 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.777 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 108' ' ' GLU . 2.0 m -87.0 105.35 17.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.751 HG13 ' N ' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -103.41 138.88 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.107 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.889 0.376 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 28' ' ' ILE . . . -148.31 151.71 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' C ' HD22 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -157.18 86.74 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.619 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 2.2 mm? -103.68 102.89 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -128.65 115.05 17.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.512 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.005 HD11 ' HB ' ' A' ' 113' ' ' VAL . 8.2 mt -82.21 162.32 22.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -152.97 111.25 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -96.45 91.96 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -26.04 50.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.34 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.15 133.4 10.14 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.647 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.981 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -57.53 -94.26 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.65 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.733 ' OG ' HG22 ' A' ' 141' ' ' VAL . 0.2 OUTLIER -178.54 171.33 1.56 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 111.316 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.751 ' N ' HG13 ' A' ' 141' ' ' VAL . . . 66.16 18.69 67.35 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.215 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 t -97.43 30.52 2.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 58.91 95.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -76.56 120.06 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.209 -178.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -72.63 143.68 48.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.959 ' O ' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -28.46 -32.21 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -177.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 98' ' ' ALA . . . -119.93 -56.46 0.25 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.336 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -6.47 110.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 122.888 1.328 . . . . 0.0 113.837 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.724 ' HA ' ' H ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -63.22 -156.77 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 112.024 -2.353 . . . . 0.0 112.071 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -166.98 -65.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.219 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.808 ' O ' HG13 ' A' ' 96' ' ' VAL . . . -104.58 113.85 27.69 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 97.4 m -116.74 93.66 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.69 0.281 . . . . 0.0 110.654 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.07 -159.46 22.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.754 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.879 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.23 137.68 10.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.734 HD11 ' N ' ' A' ' 117' ' ' CYS . 8.8 tt -109.27 153.65 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.419 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -139.67 130.01 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.704 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -125.93 -162.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.888 -135.61 54.087 71.332 103.417 2.022 103.025 90.255 95.576 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 29' ' ' CYS . 1.4 ptt85 166.08 38.82 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.165 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -144.17 170.34 16.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.928 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -70.01 110.9 5.33 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.536 ' CE1' ' CG ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.29 167.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.278 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.94 36.09 4.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.511 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.929 ' HA2' ' O ' ' A' ' 85' ' ' ARG . . . -169.2 150.76 16.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 118.629 -1.748 . . . . 0.0 116.024 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 84' ' ' SER . 3.6 m-85 -103.61 127.71 51.0 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.664 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.3 OUTLIER -110.01 109.98 20.74 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.671 HG12 ' CZ3' ' A' ' 72' ' ' TRP . 8.3 p -126.24 158.5 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.817 ' NE1' ' HA3' ' A' ' 114' ' ' GLY . 11.4 p90 -139.08 175.63 9.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.814 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.536 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -118.44 -23.61 7.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.096 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 112' ' ' SER . 0.1 OUTLIER 74.7 4.05 4.31 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.791 ' HB2' HG12 ' A' ' 54' ' ' VAL . 23.3 mm-40 -98.15 65.62 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.37 -0.206 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.94 -152.08 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' HE3' ' A' ' 40' ' ' MET . 0.8 OUTLIER -160.22 154.43 23.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' ARG . 9.0 p -107.82 131.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.864 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.1 -66.11 0.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 110.568 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.47 64.47 0.07 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.089 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -113.87 -96.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.846 ' CB ' HG13 ' A' ' 83' ' ' VAL . . . 146.12 -18.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 51' ' ' ARG . 18.5 pt-20 -92.88 -155.59 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.672 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' C ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -30.62 115.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.294 0.497 . . . . 0.0 111.196 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -151.49 131.08 13.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 64' ' ' ARG . 1.5 t -72.71 124.62 29.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.0 0.905 . . . . 0.0 111.877 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.791 HG12 ' HB2' ' A' ' 42' ' ' GLU . 14.8 m -99.64 159.79 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.432 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -106.78 175.43 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.156 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' CD2' ' A' ' 61' ' ' HIS . 3.3 p -87.45 -159.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.709 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.44 -27.77 11.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.97 20.55 6.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.429 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 38.24 70.5 0.28 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.628 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -163.92 8.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -169.32 157.97 7.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 111.142 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -121.07 142.94 49.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.237 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.006 HD22 ' CZ ' ' A' ' 111' ' ' PHE . 3.2 tt -118.24 95.89 5.08 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.32 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.725 ' HD3' HG22 ' A' ' 53' ' ' VAL . 2.3 mmt85 -53.57 159.54 1.49 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.674 -0.641 . . . . 0.0 111.408 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG13 HD23 ' A' ' 63' ' ' LEU . 17.5 m -154.45 158.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.493 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 51.7 mtp85 -138.48 137.61 37.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -175.5 -70.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.901 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -65.6 15.46 0.22 Allowed Glycine 0 CA--C 1.503 -0.707 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.606 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 67' ' ' THR . . . -143.93 13.68 2.16 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.061 -1.066 . . . . 0.0 113.768 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 69' ' ' GLY . 27.7 t70 -49.91 -61.18 2.28 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 103.549 -2.759 . . . . 0.0 103.549 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.13 5.46 0.66 Allowed Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.671 ' CZ3' HG12 ' A' ' 38' ' ' VAL . 17.3 m95 -51.38 -170.73 0.0 OUTLIER 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.044 0.937 . . . . 0.0 110.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.57 130.37 16.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.776 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 83' ' ' VAL . 22.4 Cg_endo -59.87 119.02 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.955 1.77 . . . . 0.0 111.628 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG12 ' CE1' ' A' ' 37' ' ' HIS . 63.7 t -123.28 151.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -67.49 91.37 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.99 121.37 5.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.532 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -45.49 145.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 111.073 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 81' ' ' LYS . . . 76.85 41.48 23.18 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.023 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.31 -70.75 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.732 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.16 162.55 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 112.071 -178.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.61 ' N ' ' HB1' ' A' ' 49' ' ' ALA . . . 125.63 103.25 1.38 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.538 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 68' ' ' GLY . 27.1 m -136.28 154.45 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.935 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -124.89 140.98 52.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.991 1.377 . . . . 0.0 114.3 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.929 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -105.77 177.18 1.43 Allowed Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.616 ' C ' ' O ' ' A' ' 85' ' ' ARG . 99.2 Cg_exo -38.89 134.6 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 105.964 -2.36 . . . . 0.0 105.964 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -117.74 -47.46 0.45 Allowed Glycine 0 CA--C 1.5 -0.877 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.093 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -33.31 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.646 0.736 . . . . 0.0 110.346 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.721 ' N ' ' O ' ' A' ' 87' ' ' GLY . 12.8 tp10 -54.2 142.78 24.77 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.624 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -42.91 77.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.94 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -172.89 138.75 0.81 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.481 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.728 HG22 ' CD2' ' A' ' 36' ' ' PHE . 33.1 m -130.84 122.31 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.942 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.879 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -85.22 119.84 26.04 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 14.8 p90 -98.89 131.15 45.19 Favored 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 122.058 -0.401 . . . . 0.0 110.34 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 4.1 p30 -91.42 147.39 23.06 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 23' ' ' ALA . 1.7 m -107.54 106.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.656 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -86.31 109.63 19.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.853 0.835 . . . . 0.0 110.968 -176.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -70.5 108.18 4.19 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.96 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.959 ' HA ' ' O ' ' A' ' 18' ' ' ASP . 59.2 t0 -81.3 68.06 7.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.602 0.715 . . . . 0.0 110.78 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 16' ' ' LEU . . . -77.52 -93.75 0.24 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.643 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER 84.69 72.2 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.814 0.807 . . . . 0.0 110.875 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 101' ' ' ASN . 3.4 tt0 136.56 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.249 0.62 . . . . 0.0 110.763 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.46 135.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 104' ' ' ILE . 17.2 pt -85.7 105.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.419 0.628 . . . . 0.0 112.464 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 104' ' ' ILE . . . -25.19 133.54 0.1 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.31 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 61.8 Cg_exo -50.9 161.57 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.466 2.111 . . . . 0.0 112.466 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 141' ' ' VAL . . . 124.09 -162.71 18.08 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.5 tm-20 -125.54 138.99 53.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.948 0.374 . . . . 0.0 111.369 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HE1' HG21 ' A' ' 141' ' ' VAL . 16.1 m-85 -117.64 146.83 43.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -124.16 126.99 47.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.042 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.006 ' CZ ' HD22 ' A' ' 63' ' ' LEU . 16.3 m-85 -127.27 119.51 26.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.259 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 135' ' ' GLY . 14.0 m -107.83 117.75 34.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.005 ' HB ' HD11 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -79.03 175.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.118 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.817 ' HA3' ' NE1' ' A' ' 39' ' ' TRP . . . 170.5 68.51 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.401 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' HA2' ' O ' ' A' ' 37' ' ' HIS . . . -86.22 93.18 1.84 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.61 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . -61.29 -47.58 85.33 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 117.499 0.649 . . . . 0.0 111.998 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.734 ' N ' HD11 ' A' ' 27' ' ' ILE . 0.5 OUTLIER 90.58 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.904 0.752 . . . . 0.0 110.932 -179.513 95.576 90.255 71.332 103.025 2.022 103.417 54.087 -135.61 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 117' ' ' CYS . 16.1 t -100.58 142.33 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.754 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.3 99.17 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.01 139.51 88.11 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.1 175.02 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.92 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.99 87.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.97 165.97 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -70.62 -64.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -131.11 132.01 44.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.64 152.11 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.24 -150.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.241 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 128' ' ' PHE . 2.4 p90 -156.0 117.31 3.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 111.226 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.1 p -145.58 75.93 13.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.444 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -99.64 71.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.689 2.926 . . . . 0.0 111.961 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -44.72 0.22 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.855 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' ALA . . . 61.8 152.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.615 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.619 ' CG2' ' HB2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -52.71 172.85 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 133' ' ' THR . 75.8 p -145.39 145.9 31.34 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.907 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.807 ' HA3' HG12 ' A' ' 113' ' ' VAL . . . -157.4 159.38 29.72 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.604 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -110.85 171.49 7.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.967 -0.617 . . . . 0.0 110.051 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.591 HG21 ' CB ' ' A' ' 23' ' ' ALA . 2.5 m 177.14 95.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -110.86 137.14 48.88 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.538 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -97.21 112.99 24.54 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.777 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 108' ' ' GLU . 2.0 m -87.0 105.35 17.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.751 HG13 ' N ' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -103.41 138.88 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.107 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.843 . . . . . . . . 0 0 . 1 stop_ save_